Technique for preclinical evaluation of continuous infusion chemotherapy with the use of WF rat acute myelogenous leukemia
- PMID: 155752
Technique for preclinical evaluation of continuous infusion chemotherapy with the use of WF rat acute myelogenous leukemia
Abstract
A technique was developed for continuous iv infusion chemotherapy in an inbred rat model of acute myelogenous leukemia. Polyethylene tubing was inserted surgically into the internal jugular vein of adult WF rats, burrowed sc to the base of the tail, and connected to an infusion pump. A flexible spring was sutured at the base of the tail and fastened to the cage wall; it protected the infusion catheter and allowed movement of the rat within the cage. This technique was used to compare bolus with continuous infusion therapy with adriamycin, cytosine arabinoside, and neocarzinostatin. Only small differences were noted in host toxicity and in antitumor effect against tumor grown as a subcutaneous myeloblastoma. Nearly three times more neocarzinostatin was required by continuous infusion for an effect equivalent to that of bolus injection. In contrast, continuous infusion of methotrexate with concurrent thymidine infusion prevented toxicity, enhanced the antitumor effect, and prolonged survival. This infusion system should facilitate rapid preclinical evaluation of drugs considered for constant iv infusion therapy.
Similar articles
-
[Continuous venous infusion in cancer chemotherapy].Gan To Kagaku Ryoho. 1985 Apr;12(4):798-805. Gan To Kagaku Ryoho. 1985. PMID: 2580486 Japanese.
-
Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.Cancer Treat Rep. 1980 Jan;64(1):81-6. Cancer Treat Rep. 1980. PMID: 7379059
-
Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome.Semin Oncol. 1993 Dec;20(6 Suppl 8):1-5. Semin Oncol. 1993. PMID: 8290966 Clinical Trial.
-
Leukemia: A model for drug development.Clin Cancer Res. 1997 Dec;3(12 Pt 2):2598-604. Clin Cancer Res. 1997. PMID: 9815664 Review.
-
A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia.Hematol Oncol. 2004 Jun;22(2):43-53. doi: 10.1002/hon.726. Hematol Oncol. 2004. PMID: 15386563 Review.